Applicant, as named in the Orange Book

Springworks

Next listed expiry: Ogsiveo on 19 May 2043. 3 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Ogsiveo NDA 217677 · 2 strengths nirogacestat hydrobromide	nirogacestat hydrobromide	19 May 2043 patent, carve-out possible	patent, carve-out possible
Gomekli NDA 219379 · 3 strengths mirdametinib	mirdametinib	10 Oct 2044 patent, carve-out possible	patent, carve-out possible
Gomekli NDA 219389 · 2 strengths mirdametinib	mirdametinib	10 Oct 2044 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.